Aryl-ester phosphoramidate derivatives of nucleosides

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 19/20 (2006.01) A61K 31/7064 (2006.01) C07H 19/10 (2006.01) A61K 31/675 (2006.01) C07F 9/6512 (2006.01) C07F 9/6561 (2006.01)

Patent

CA 2215190

The invention relates to masked monophosphate nucleoside analogues, their preparation and their therapeutic use in the treatment of viral infection, including infection by HIV. In particular, the invention relates to aryl phosphoramidate 2',3'-dideoxy and 2',3'-dideoxydidehydro of nucleoside analogues and of PMEA.

L'invention concerne des analogues de nucléosides monophosphatés masqués, leur préparation et leur usage thérapeutique dans le traitement des infections virales, notamment l'infection par le VIH. L'invention concerne en particulier le 2',3'-didésoxy et le 2',3'-didésoxydidéhydro arylphosphoramidate d'analogues de nucléosides et de PMEA.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Aryl-ester phosphoramidate derivatives of nucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aryl-ester phosphoramidate derivatives of nucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl-ester phosphoramidate derivatives of nucleosides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2018412

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.